These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 898726)
1. [Diagnostic importance of permanganate test in neurological diseases]. Ronskiĭ MA; Zakharov VP; Deliamure LL Voen Med Zh; 1977 Mar; (3):65. PubMed ID: 898726 [No Abstract] [Full Text] [Related]
2. [Spinal fluid diagnostic test using potassium permanganate in certain nervous diseases]. Kostruba NN Vrach Delo; 1973 Feb; 2():120-3. PubMed ID: 4722311 [No Abstract] [Full Text] [Related]
3. [Studies on the determination of reduction in cerebrospinal fluid]. Krause H; Neumann J Wien Z Nervenheilkd Grenzgeb; 1968; 26(4):285-92. PubMed ID: 4241204 [No Abstract] [Full Text] [Related]
4. [Usefulness of potassium permanganate staining in the classification of systemic amyloidoses]. Pigrau C; Martínez-Vázquez JM; Ocaña I; Capdevila JA; Ribera E; Muñiz R; Vidal MT Med Clin (Barc); 1985 Mar; 84(8):302-4. PubMed ID: 2580195 [No Abstract] [Full Text] [Related]
5. Characterization of spontaneous amyloidosis of Syrian hamsters using the potassium permanganate method. Mezza LE; Quimby FW; Durham SK; Lewis RM Lab Anim Sci; 1984 Aug; 34(4):376-80. PubMed ID: 6482376 [TBL] [Abstract][Full Text] [Related]
6. Difference in potassium permanganate sensitivity between primary and secondary amyloidosis. Looi LM; Lim MY Malays J Pathol; 1981 Aug; 4():65-8. PubMed ID: 7186605 [No Abstract] [Full Text] [Related]
7. [Use of the potassium permanganate technique in the differential diagnosis of amyloidoses]. Podzamczer D; Vidaller A; Sancho S; González MT; Comellas J; Fernández Nogués F Med Clin (Barc); 1985 Mar; 84(8):305-7. PubMed ID: 3982153 [No Abstract] [Full Text] [Related]
8. [Discriminative value of potassium permanganate staining in systemic amyloidosis]. González-García JJ; Vicandi B; Peña JM; García Alegría J; Lorente JA; Domínguez A; Santamaría P; Picazo ML Rev Clin Esp; 1987 Feb; 180(3):132-5. PubMed ID: 2437621 [No Abstract] [Full Text] [Related]
9. [A contribution to the characterization of urinary colloids after paper electrophoresis using potassium permanganate]. Wachter H; Hohenwallner W Wien Klin Wochenschr; 1965 Dec; 77(52):1040. PubMed ID: 5871996 [No Abstract] [Full Text] [Related]
10. [ON THE DIAGNOSTIC SIGNIFICANCE OF THE PERMANGANATE REDUCTION REACTION IN NEUROLOGICAL PRACTICE]. SLIUSAREV FM; MATKOVSKII EI Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():833-6. PubMed ID: 14235910 [No Abstract] [Full Text] [Related]
11. [Systemic amyloidosis in Hodgkin's disease: presentation of 2 cases]. Peña JM; de Miguel E; González JJ; García-Alegría J; Barbado FJ; Arnalich F; Ortiz Vázquez J Rev Clin Esp; 1986 Nov; 179(7):359-61. PubMed ID: 3797748 [No Abstract] [Full Text] [Related]
12. [The cerebrospinal fluid concentrations of beta-glucuronidase and beta 2-microglobulin in neurological disorders]. Oda R; Hirose G; Emori T No To Shinkei; 1985 Feb; 37(2):155-60. PubMed ID: 3890905 [TBL] [Abstract][Full Text] [Related]
13. Observations on the ultrastructural localization of monoamines with permanganate fixation. Kanerva L; Hervonen A; Grönblad M Adv Biochem Psychopharmacol; 1980; 25():279-85. PubMed ID: 7446260 [No Abstract] [Full Text] [Related]
14. [Usefulness of the determination of serum and cerebrospinal fluid immunoglobulins in the diagnosis of nervous system pathology]. Ioppoli C; Consoloni E; Cioni M; Amerighi A Minerva Med; 1980 Jan; 71(2):97-101. PubMed ID: 7354932 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of permanganate and manganous ions as scanning agents. Roda JE; Soloway AH; Benda P; Sweet WH Neurochirurgia (Stuttg); 1968 Nov; 11(6):246-52. PubMed ID: 5712300 [No Abstract] [Full Text] [Related]